|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/1272 | (2013.01) | ||
| A61K 9/107 | (2006.01) | ||
| A61K 48/00 | (2013.01) | ||
| A61K 31/663 | (2013.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/7105 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 31/7105 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 31/663 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 9/1075 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3277263 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16712339.7 |
| Europos patento paraiškos padavimo data | 2016-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/056920 |
| Data | 2016-03-30 |
| (87) | Numeris | WO 2016/156398 |
| Data | 2016-10-06 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2015/057118 | 2015-03-31 | WO |
| (72) |
HEFESHA, Hossam , DE
SAHIN, Ugur , DE
HAAS, Heinrich , DE
KREITER, Sebastian , DE
HÜSEMANN, Yves , DE
DIKEN, Mustafa , DE
REUTER, Kerstin , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (54) | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL |
| LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL |